Life sciences: Primed for an increase
M&A activity in the life science sector fell in 2024, but several factors, including pent-up demand and the state of companies’ pipelines, point to a strong rebound in dealmaking in 2025.

Mar 14, 2025 0
Mar 14, 2025 0
Mar 14, 2025 0
Mar 14, 2025 0
Mar 14, 2025 0
Mar 14, 2025 0
Or register with email
Jan 27, 2025 0
Jan 28, 2025 0
Mar 1, 2025 0
Feb 24, 2025 0
Feb 24, 2025 0
Jan 30, 2025 1
Jan 29, 2025 0
Jan 28, 2025 0
This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.